Enkephalin Therapy Improves Relapsing-Remitting Multiple Sclerosis

From An Overview and Management of Multiple Chronic Conditions, Edited by Sevgi Akarsu
28 January 2020
https://www.intechopen.com/online-first/enkephalin-therapy-improves-relapsing-remitting-multiple-sclerosis

The Uses of Low-Dose Naltrexone in Clinical Practice

BMJ Case Reports
January 2018
https://www.researchgate.net/publication/328997819_Issue_4_The_Uses_of_Low-Dose_Naltrexone_in_Clinical_Practice

Off-label, Low-Dose Naltrexone for Refractory Chronic Low Back Pain

Pain Med
May 2014
https://europepmc.org/article/med/24967470

Dr. Armin Schwarzbach, Infections in Cancer and Autoimmune Disorders. Presented by Markus Berger.

The Benefits of Low Dose Naltrexone

JewishLink
21 May 2020
https://jewishlink.news/monthly-sections/health-link-new/37942-the-benefits-of-low-dose-naltrexone

MS breakthrough: Cancer drug repairs damaged myelin nerve tissue in human trials first

The Herald
25 September 2020
https://www.heraldscotland.com/news/18748293.ms-breakthrough-cancer-drug-repairs-damaged-myelin-nerve-tissue-human-trials-first/

Experimental autoimmune encephalopathy (EAE)-induced hippocampal neuroinflammation and memory deficits are prevented with the non-opioid TLR2/TLR4 antagonist (+)-naltrexone

Behav Brain Res
01 Jan 2021
https://pubmed.ncbi.nlm.nih.gov/32905811/

[Met 5]-enkephalin preserves diffusion metrics in EAE mice (Abstract)

Brain Res Bull
December 2020
https://pubmed.ncbi.nlm.nih.gov/33141073/

Cameon LDN and Multiple Sclerosis (MS) (low dose naltrexone) from LDN Research Trust on Vimeo.

Cameon from the USA shares her story of going from 7 years in a wheelchair to walking, after taking Low Dose Naltrexone for 10 months. 

Her speech is slow but improved as one of the symptoms he suffered from Multiple Sclerosis (MS). 

Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills?

Medscape Medical News
11 Mar 2020
https://www.medscape.com/viewarticle/926611?src=WNL_trdalrt_201027_MSCPEDIT&uac=267476HJ&impID=2640101&f